Back to search
FDAFDA · Food and drugs·Recall number Z-1019-2022

Flo-Thru Intraluminal Shunt. Used in coronary artery or peripheral vascular procedures. Used to shunt blood at the anastomosis to provide a temporary blood-free operative field for suturing while allowing blood to flow distal to the anastomosis.

Published May 11, 2022 · Recall initiated: April 1, 2022

Summary

FDA records medical device Class II recall Z-1019-2022, published May 11, 2022 and initiated April 1, 2022. Recalling firm: Baxter Healthcare Corporation; Status: Terminated; Reported quantity: 300 devices; Lot: Product Code: FT12150; Lot: SP21J21-1584173. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

There is a potential for foreign matter.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Baxter Healthcare Corporation
Distributor
Distribution in the United States including AL, CA, KY, NY, OR, PA, and TX OUS distribution to Japan, Italy, Netherlands, Switzerland, and United Kingdom
Lot
Product Code: FT12150; Lot: SP21J21-1584173
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was Flo-Thru Intraluminal Shunt. Used in coronary artery or peripheral vascular procedures. Used to shunt blood at the anastomosis to provide a temporary blood-free operative field for suturing while allowing blood to flow distal to the anastomosis. recalled?

Yes. FDA published recall Z-1019-2022 on May 11, 2022. Reported hazard: There is a potential for foreign matter.

What should I do if I have this product?

Voluntary: Firm initiated · Letter